NO308851B1 - Fusjonerte indol- og kinoksalderivater, farmasøytisk blanding og anvendelse av forbindelsen - Google Patents
Fusjonerte indol- og kinoksalderivater, farmasøytisk blanding og anvendelse av forbindelsenInfo
- Publication number
- NO308851B1 NO308851B1 NO970903A NO970903A NO308851B1 NO 308851 B1 NO308851 B1 NO 308851B1 NO 970903 A NO970903 A NO 970903A NO 970903 A NO970903 A NO 970903A NO 308851 B1 NO308851 B1 NO 308851B1
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- hydrogen
- amino
- alkoxy
- phenyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 title 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 9
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 6
- -1 hydroxy, amino Chemical group 0.000 abstract 5
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000001424 substituent group Chemical group 0.000 abstract 4
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical group O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 125000005843 halogen group Chemical group 0.000 abstract 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
- 125000004429 atom Chemical group 0.000 abstract 1
- 125000005605 benzo group Chemical group 0.000 abstract 1
- 208000026106 cerebrovascular disease Diseases 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK105494 | 1994-09-14 | ||
| PCT/EP1995/003594 WO1996008495A1 (en) | 1994-09-14 | 1995-09-12 | Fused indole and quinoxaline derivatives, their preparation and use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO970903D0 NO970903D0 (no) | 1997-02-27 |
| NO970903L NO970903L (no) | 1997-05-07 |
| NO308851B1 true NO308851B1 (no) | 2000-11-06 |
Family
ID=8100467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO970903A NO308851B1 (no) | 1994-09-14 | 1997-02-27 | Fusjonerte indol- og kinoksalderivater, farmasøytisk blanding og anvendelse av forbindelsen |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5801174A (no) |
| EP (1) | EP0781285B1 (no) |
| JP (1) | JP3164372B2 (no) |
| AT (1) | ATE188701T1 (no) |
| AU (1) | AU686888B2 (no) |
| CA (1) | CA2199614C (no) |
| DE (1) | DE69514533T2 (no) |
| EE (1) | EE03772B1 (no) |
| FI (1) | FI112486B (no) |
| NO (1) | NO308851B1 (no) |
| NZ (1) | NZ293266A (no) |
| WO (1) | WO1996008495A1 (no) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA54403C2 (uk) * | 1996-10-01 | 2003-03-17 | Н'Юросерч А/С | Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму |
| FR2781482B1 (fr) * | 1998-07-27 | 2001-08-31 | Adir | Nouveaux derives de 8h-thieno-[2,3-b]pyrrolizine-8-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| CA2369746A1 (en) * | 1999-05-19 | 2000-11-30 | Neurosearch A/S | Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders |
| CN1298704C (zh) * | 2000-01-24 | 2007-02-07 | 神经研究公司 | 具有神经营养活性的靛红衍生物 |
| US7718641B2 (en) | 2005-11-23 | 2010-05-18 | Aros Pharma Aps | Pyrrolo [3,4-H] isoquinoline compounds and methods for modulating gated ion channels |
| WO2007070506A2 (en) | 2005-12-14 | 2007-06-21 | Amgen Inc. | Diaza heterocyclic sulfonamide derivatives and their uses |
| CA2652307A1 (en) * | 2006-04-10 | 2007-10-18 | Painceptor Pharma Corporation | Compositions and methods for modulating gated ion channels |
| WO2008144931A1 (en) * | 2007-05-30 | 2008-12-04 | Painceptor Pharma Corporation | Compositions and methods for modulating gated ion channels |
| CA2868238A1 (en) | 2012-04-18 | 2013-10-24 | Ramot At Tel Aviv University Ltd. | Lipidated glycosaminoglycan particles for the delivery of nucleic acids |
| WO2016114655A1 (en) * | 2015-01-12 | 2016-07-21 | Ry Pharma B.V. | Treating neuromuscular or neurologic disease through reducing gabaergic and/or glycinergic inhibitory neurotransmitter overstimulation |
| WO2017065602A1 (en) * | 2015-10-13 | 2017-04-20 | Ry Pharma B.V. | Treating neuromuscular or neurologic disease through reducing gabaergic and/or glycinergic inhibitory neurotransmitter overstimulation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9204914A (es) * | 1991-08-28 | 1993-07-01 | Frank Watjen | Nuevos derivados de isatinoxima, metodo para su preparacion y composicion farmaceutica que los comprende. |
| ES2109516T3 (es) * | 1992-10-13 | 1998-01-16 | Warner Lambert Co | Derivados de quinoxalinodiona como antagonistas de aminoacidos excitadores. |
-
1995
- 1995-09-12 NZ NZ293266A patent/NZ293266A/en unknown
- 1995-09-12 EP EP95932730A patent/EP0781285B1/en not_active Expired - Lifetime
- 1995-09-12 WO PCT/EP1995/003594 patent/WO1996008495A1/en active IP Right Grant
- 1995-09-12 DE DE69514533T patent/DE69514533T2/de not_active Expired - Lifetime
- 1995-09-12 AU AU35665/95A patent/AU686888B2/en not_active Ceased
- 1995-09-12 JP JP50990896A patent/JP3164372B2/ja not_active Expired - Fee Related
- 1995-09-12 EE EE9700051A patent/EE03772B1/xx not_active IP Right Cessation
- 1995-09-12 AT AT95932730T patent/ATE188701T1/de not_active IP Right Cessation
- 1995-09-12 US US08/809,086 patent/US5801174A/en not_active Expired - Lifetime
- 1995-09-12 CA CA002199614A patent/CA2199614C/en not_active Expired - Fee Related
-
1997
- 1997-02-25 FI FI970785A patent/FI112486B/fi active
- 1997-02-27 NO NO970903A patent/NO308851B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EE9700051A (et) | 1997-08-15 |
| CA2199614C (en) | 2000-02-22 |
| EP0781285A1 (en) | 1997-07-02 |
| AU3566595A (en) | 1996-03-29 |
| NO970903L (no) | 1997-05-07 |
| DE69514533T2 (de) | 2000-07-06 |
| AU686888B2 (en) | 1998-02-12 |
| US5801174A (en) | 1998-09-01 |
| DE69514533D1 (de) | 2000-02-17 |
| FI970785A (fi) | 1997-03-13 |
| NO970903D0 (no) | 1997-02-27 |
| EP0781285B1 (en) | 2000-01-12 |
| FI112486B (fi) | 2003-12-15 |
| WO1996008495A1 (en) | 1996-03-21 |
| NZ293266A (en) | 1998-01-26 |
| ATE188701T1 (de) | 2000-01-15 |
| JP3164372B2 (ja) | 2001-05-08 |
| EE03772B1 (et) | 2002-06-17 |
| FI970785A0 (fi) | 1997-02-25 |
| CA2199614A1 (en) | 1996-03-21 |
| JPH09511525A (ja) | 1997-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG128491A1 (en) | Heterocyclic sulfonamide inhibitors of beta amyloid production | |
| AR007440A1 (es) | Compuestos triciclos fenilamino sustituidos y composiciones farmaceuticas de los mismos. | |
| NO308851B1 (no) | Fusjonerte indol- og kinoksalderivater, farmasøytisk blanding og anvendelse av forbindelsen | |
| NO981609L (no) | Fusjonerte tropanderivater som inhiberer for neurotransmitteropptak | |
| TR200100698T2 (tr) | 5-HT4 alıcı-Antagonistleri olarak Dihidrobenzodioksin Karboksamit ve Keton türevleri | |
| ATE275545T1 (de) | Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d | |
| ATE222587T1 (de) | TROPAN-2-ALDOXIMDERIVATE ALS NEUROTRANSMITTER ßREUPTAKEß INHIBITOREN | |
| NZ528997A (en) | Sulfonamides | |
| ATE161259T1 (de) | Ampa antagonisten und behandlungsmethode | |
| ATE236636T1 (de) | Hexahydro-pyrido (4,3-b)indolderivate als antipsychotische arzneimittel | |
| NO308852B1 (no) | Indol-2,3-dion-3-oksim-derivater, farmasøytisk blanding og anvendelse av forbindelsen | |
| MXPA04005077A (es) | Derivados de benzotiazol. | |
| DE69510510D1 (de) | N-benzoylmethylsubstituierte paroxetinderivate | |
| DK0699197T3 (da) | 4-p-flourbenzoyl-1-piperidinyl-propoxy-chromen-4-on-derivater, deres fremstilling og deres anvendelse i behandlingen af psy | |
| ES2161892T3 (es) | Derivados de indol como profarmacos de agonistas de los receptores afines a 5-ht1. |